Capstar Can Help Under an Emergency Authorization—but It Does Not Stop Screwworm Exposure
Yes—with important limits. On September 3, 2026, the FDA issued an Emergency Use Authorization allowing Capstar to prevent and treat New World screwworm larval infestations in eligible dogs and cats. That was an emergency authorization, not ordinary FDA approval for routine screwworm prevention. Capstar kills larvae after they hatch; it does not repel adult flies, stop egg laying, or prevent eggs from hatching.
A dog with visible maggots, a foul-smelling wound, or suspected larvae around the eyes, ears, nose, mouth, or another body opening needs immediate veterinary care even if Capstar has already been given, according to the FDA’s September 3 announcement.
Status note: The sources cited here establish the authorization as of September 3, 2026. Because an EUA can be revised, revoked, or terminated, that dated authorization should not be treated as proof that the same conditions remain in effect indefinitely.
The short answer: yes, but only under the FDA emergency authorization
As of September 3, 2026, Capstar had a defined emergency-authorized role in preventing and treating New World screwworm in dogs and cats that met the authorization’s minimum age and weight conditions.
The answer is therefore a qualified yes. It is not a blanket recommendation to give Capstar whenever exposure seems possible. The authorized screwworm use has its own conditions, separate from the product’s ordinary flea instructions. Owners should not create a regimen, extend a flea-control routine, or assume that another nitenpyram product can be used in the same way.
The FDA’s veterinarian information page lists Capstar and nitenpyram products authorized in connection with New World screwworm and emphasizes that EUA products are authorized for emergency use but are not FDA-approved for that use. Before relying on Capstar, check the current FDA New World screwworm drug information and ask a veterinarian whether the dog, exact product, and intended use qualify.
Medication also does not make a suspicious wound safe to watch at home. If a dog may already be infested, the immediate decision is to seek veterinary care—not to wait and see whether a tablet resolves the wound.
What Capstar prevention does—and does not—mean
Under the September 3 EUA, Capstar’s preventive action occurred after a screwworm fly deposited eggs and those eggs hatched. The drug was intended to kill newly hatched larvae before an infestation became established.
| Protection question | What Capstar did under the EUA |
|---|---|
| Kills newly hatched larvae | Yes, when used as authorized |
| Repels adult screwworm flies | No |
| Stops flies from laying eggs | No |
| Prevents deposited eggs from hatching | No |
Capstar contains nitenpyram and is ordinarily approved for killing adult fleas and treating flea infestations. The emergency screwworm use was separate. The FDA’s authorization summary states that Capstar does not kill or repel adult screwworm flies, prevent egg deposition, stop eggs from hatching, or prevent newly hatched larvae from beginning to feed before they are killed (FDA Capstar EUA summary).
That distinction matters. Giving Capstar according to an ordinary flea routine should not automatically be considered screwworm protection. Do not assume that every package strength, nitenpyram product, or flea-control schedule satisfies the emergency-use conditions.
Capstar also cannot replace exposure precautions. Continue checking the dog’s skin and any cuts, bites, surgical sites, or irritated areas, particularly after relevant travel or outdoor exposure. Inspect around the eyes, ears, nose, mouth, and other body openings, and seek veterinary advice about wounds rather than relying on medication to conceal or prevent a developing problem.
Emergency authorization is not the same as ordinary FDA approval
An EUA permits a specific product to be used for a specified purpose during an emergency when the applicable legal standard is met. It is not ordinary FDA approval for that new indication. A 2026 Federal Register notice likewise distinguishes animal-drug emergency authorizations from FDA approvals and documents earlier treatment-focused authorizations issued during the New World screwworm response (Federal Register notice).
For Capstar, keep three uses separate:
- Ordinary approved use: killing adult fleas and treating flea infestations.
- Emergency-authorized prevention: killing newly hatched New World screwworm larvae before an infestation becomes established, subject to the EUA.
- Emergency-authorized treatment: killing larvae in an animal with an existing infestation, again subject to the EUA.
The timeline explains why credible sources can appear to conflict:
- Before the 2026 response: Capstar’s established approval concerned fleas.
- Earlier in 2026: federal materials and the available dog study focused on treatment of existing infestations.
- September 3, 2026: the FDA announced a Capstar EUA covering both prevention and treatment under specified conditions.
An older article saying nitenpyram treats screwworm but does not provide continuing prevention may accurately describe the authorization in effect when that article was written. It does not necessarily account for the later preventive use. The date, product, and regulatory action all matter.
Use this three-step wound and exposure check
What you can see on the dog determines how quickly to act. Whether Capstar has already been given does not change the urgency of visible larvae or a rapidly worsening wound.
1. No suspicious wound or visible larvae: check regularly and verify guidance
If the dog has no unexplained wound, odor, discharge, eggs, or larvae, continue regular skin checks after relevant travel or exposure. Part the coat and inspect existing cuts, bites, irritated skin, surgical sites, and the areas around body openings.
This is the stage for asking a veterinarian about prevention—not starting a self-directed emergency-use routine. Exposure areas and travel rules can change. For context, an AAHA report documented canine cases and inspection requirements affecting dogs entering the United States from Mexico during June 2026. Those dated events demonstrate that exposure was possible, but they do not establish current regional risk or prove that Capstar will protect an individual dog (AAHA’s June 2026 update).
2. New or worsening wound without visible larvae: call a veterinarian promptly
Contact a veterinarian promptly if a wound is:
- New or unexplained
- Enlarging or deepening
- Draining blood, serum, or pus
- Painful or attracting persistent licking
- Swollen or foul-smelling
- Failing to improve as expected
A home inspection cannot reliably exclude infestation because larvae may be deeper in a wound. An enlarging, draining, painful, or foul-smelling wound needs assessment regardless of its cause. Tell the clinic about recent travel, known exposure, outdoor activity, and any parasite medication already given.
3. Visible eggs, maggots, or movement: go now
Seek immediate veterinary care if you see:
- Maggots or clustered eggs in or around a wound
- Movement within a wound
- Rapid enlargement or deterioration
- A strong foul or decaying odor
- Larvae near the eyes, ears, nose, mouth, or another body opening
- Marked pain, depression, or reduced appetite with a suspicious wound
CDC described the U.S. public-health risk as very low as of August 11, 2026, while advising people to seek care for maggots, unexplained sores, foul odor, or movement in the nose, mouth, or ears (CDC situation summary). That dated population-level assessment does not make compatible signs in an individual dog less urgent.
Worked example: You gave Capstar after a possible exposure, but you can still see maggots moving in the wound. Do not wait for the medication to “finish the job.” The dog needs urgent examination because larvae may remain and the wound may already require cleaning, larval removal, pain control, or treatment for complications.
Why Capstar cannot replace veterinary wound care
Medication can kill larvae without removing every larva or repairing the tissue damage they caused. In the small dog study considered by the FDA, most larvae were expelled during observation, but dead larvae that remained had to be removed mechanically. That finding is one reason treatment of an established infestation cannot be reduced to giving a tablet.
Depending on the wound, a veterinarian may need to:
- Examine its depth and extent
- Collect larvae for identification
- Remove remaining live or dead larvae
- Clean and assess damaged tissue
- Address pain or secondary infection
- Examine affected body openings
- Arrange follow-up inspection
Leave larval identification and removal to a veterinarian unless one specifically directs otherwise. Larvae can occur at different depths, and a dog may need more extensive examination than the visible surface suggests. Veterinary guidance for suspected cases calls for removal of eggs and larvae, thorough wound cleaning, appropriate systemic treatment, and reinspection; additional wound care, pain relief, or antimicrobial treatment may be needed depending on severity.
New World screwworm is particularly dangerous because the larvae feed on living tissue. As more larvae hatch and feed, the wound can enlarge and deepen. Untreated infestation can cause extensive tissue damage and may be fatal.
Capstar and veterinary wound care therefore perform different jobs. The medication targets larvae. The veterinary examination addresses removal, tissue injury, pain, contamination, complications, identification, and recovery.
How certain is the evidence?
The EUA did not establish that Capstar would always prevent screwworm. The FDA’s emergency standard was that it was reasonable to believe the product might be effective when used as authorized and that its known and potential benefits outweighed its known and potential risks. That is not guaranteed protection or the same evidentiary conclusion as ordinary approval for routine prevention.
The New World screwworm dog evidence cited by FDA included an uncontrolled study of seven naturally infested dogs. It evaluated treatment of existing infestation—not prevention in exposed but uninfested dogs. Most larvae were expelled during the observation period, while the remaining dead larvae required mechanical removal (FDA authorization evidence summary).
The limitations are important:
- The study included only seven dogs.
- It had no untreated comparison group.
- It studied treatment rather than preventive performance.
- It did not test whether Capstar blocks fly contact, egg laying, or hatching.
- Mechanical removal was still required for larvae remaining in the wounds.
A treatment efficacy percentage from that study should not be presented as proof that preventive use will protect every dog. The authorization combined limited evidence with an emergency risk-benefit judgment; it did not remove uncertainty.
The practical judgment is straightforward: Capstar had an emergency-authorized preventive role as of September 3, 2026, but it did not block flies or eggs and could not make a suspicious wound safe to monitor. Verify the FDA’s current authorization before relying on it, continue checking exposed dogs for wounds, and seek immediate veterinary care for maggots, foul odor, rapid wound changes, or movement around a body opening.